期刊文献+

5-HT_(2B)受体阻断剂对心肌肥厚大鼠心肌5-HT含量及5-HT_(2B)受体表达的影响 被引量:2

Effect of 5-HT_(2B) receptor antagonist on level of 5-HT and expression of 5-HT_(2B) receptor in cardiac hypertrophy induced by norepinephrine in rats
下载PDF
导出
摘要 目的观察5-HT2B受体阻断剂对去甲肾上腺素(norepinephrine,NE)诱导的心肌肥厚大鼠心肌中5-羟色胺(5-hydrotriptamine,5-HT)含量及5-HT2B受体表达的影响。方法雄性SD大鼠24只,随机分为3组,8只/组,分别为对照组、肥厚组、实验组。采用腹腔注射NE(1.5 mg/kg,2次/d,28 d)的方法建立心肌肥厚模型,自第15天起实验组腹腔注射SB204741(5-HT2B受体阻断剂;2 mg/kg,2次/d),连续注射14 d。对照组腹腔注射相同体积的生理盐水(2次/d,28 d)。检测各组左心室重量与体重之比(LVW/BW)、心肌组织中5-HT的含量及5-HT2B受体的表达情况。结果在NE诱导心肌肥厚过程中,应用SB204741干预可显著减轻心肌肥厚的程度,降低心肌组织中5-HT的含量,并抑制5-HT2B受体表达的上调。结论应用5-HT2B受体阻断剂可减轻NE诱导心肌肥厚的程度,降低心肌组织中5-HT的含量,并抑制5-HT2B受体表达的上调。 Objective To observe the effect of 5-HT2B receptor antagonist on level of 5-hydrotriptamine(5- HT) and expression of 5-HT2B receptor in cardiac hypertrophy induced by norepinephrine in rats. Methods Experiments were performed on Sprague-13awley rats weighing 180-220 g. To induce ventricular hypertrophy, rats were injected with norepinephrine(i.p., 1.5 mg/kg) twice daily for 28 days. Starting on the Day 15, 5-HT2B receptor antagonist SB 204741 (i.p., 2 mg/kg, in study group, n=8) was injected twice daily for another 14 days in the norepinephrine-injected rats. In control group, normal saline (n=8) was injected twice daily for 28 days. Ratios of left ventricular weight to body weight (LVW/BW), levels of 5-HT in left ventricular tissues and expressions of 5- HT2B receptor were detected after rats had been decapitated. Results Rats treated with norepinephrine developed cardiac hypertrophy as indicated by increased LVW/BW. In the meantime, the levels of 5-HT and expressions of 5-HT2B receptor increased significantly in left ventricular tissues. Blockade of 5-HT2B receptor by SB204741 significantly attenuated the degree of cardiac hypertrophy and levels of 5-HT and inhibited the up-regulation of expression of 5-HT2B receptor in norepinephrine-injected rats. Conclusion In the process of cardiac hypertrophy induced by norepinephrine over-stimulation, 5-HT2B receptor antagonist could attenuate the degree of cardiac hypertrophy and level of 5-HT and inhibit up-regulation of expression of 5-HT2B receptor in myocardial tissue.
机构地区 [
出处 《实用医药杂志》 2013年第5期429-431,共3页 Practical Journal of Medicine & Pharmacy
关键词 5-HT2B受体 阻断剂 去甲肾上腺素 心肌肥厚 大鼠 5-HT2B receptor Antagonist Norepinephrine Cardiac hypertrophy Rat
  • 相关文献

参考文献12

  • 1Correa-Araujo R.,Oliveira JS,Ricciardi Cruz A. Cardiac levels of norepinephrine,dopamine,serotonin and histamine in Chagas" disease[J]. Int J Cardiol,1991,31(3):329-36.
  • 2Nebigil CG. Overexpression of the serotonin 5-HT receptor inheart leads to abnormal mitoehondrial function and cardiac hy- pertrophy[J]. Circulation,2003,107(25):3223-9.
  • 3I Kaumann AJ,Levy FO. 5-hydroxytryptamine receptors in the human cardiovascular system[J]. Pharmaeol Ther,2006,111(3): 674-706.
  • 4Chandra M. Serotonergic mechanisms in heart failure[J]. Indian Heart J, 1994,46(4) : 153-6.
  • 5Sole MJ,Shum A,van Loon GR. Serotonin metabolism in the no- rmal and failing hamster heart[J]. Circ Res,1979,45(5):629-34.
  • 6Fu YC. Norepinephfine induces apoptosis in neonatal rat cardi- omyocytes through a reactive oxygen species-TNF alpha-caspase signaling pathway[J]. Cardiovasc Res,2004,62(3):558-67.
  • 7Brown L. Cardiac responses after norepinephrine-induced ven- tficular hypertrophy in rats[J]. J Cardiovasc Pharmacol,1992,20 (2) : 316-23.
  • 8Post GR,Brewn JH. G protein-coupled receptors and signaling pathways regulating growth responses[J]. FASEBJ, 1996,10 (7) : 741-749.
  • 9Nebigil CG. Serotonin 2B receptor is required for heart deve- lopment[J]. Proc Natl Acad Sci USA,2000,97(17):9508-13.
  • 10Shyu KG. Semtonin 5-HT receptor in cardiac fihmblast con- tributes to cardiac hypertrophy:a new therapeutic target for heart failure?[J]. Circ Res,2009,104(1) : 1-3.

同被引文献34

  • 1张冬颖,罗羽慧,杨辉,覃数,李法琦.冠状动脉结扎与腹主动脉缩窄所致慢性心力衰竭大鼠模型比较[J].中国微循环,2005,9(3):171-174. 被引量:30
  • 2Diwan A,Wansapura J,Syed FM,et al.Nix-mediated apoptosis links myocardial fibrosis,cardiac remodeling,and hypertrophy decompensation[J].Circulation,2008,117(3):396-404.
  • 3Bharti S,Singh R,Chauhan SS,et al.Phosphorylation of Akt/GSK-3β/eNOS amplifies 5-HT2B receptor blockade mediated anti-hypertrophic effect in rats[J].FEBS Letters,2012,586(2):180-5.
  • 4Shyu KG.Serotonin 5-HT2B receptor in cardiac fibroblast contributes to cardiac hypertrophy:a new therapeutic target for heart failure?[J].Circ Res,2009,104(1):1-3.
  • 5Monassier L,Laplante MA,Jaffre F,et al.Serotonin 5-HT(2B)receptor blockade prevents reactive oxygen species-induced cardiac hypertrophy in mice[J].Hypertension,2008,52(2):301-7.
  • 6Hughes SE.The pathology of hypertrophic cardiomyopathy[J].Histopathology,2004,44(5):412-27.
  • 7Dorn GW.Apoptotic and non-apoptotic programmed cardiomyocyte death in ventricular remodelling[J].Cardiovasc Res,2009,81(3):465-73.
  • 8Steller H.Mechanisms and genes of cellular suicide[J].Science,1995,267(5203):1445-9.
  • 9Brown L,Sernia C,Newling R,et al.Cardiac responses after norepinephrine-induced ventricular hypertrophy in rats[J].J Cardiovasc Pharmacol,1992,20(2):316-23.
  • 10Kuster GM,Pimentel DR,Adachi T,et al.Alpha-adrenergic receptor-stimulated hypertrophy in adult rat ventricular myocytes is mediated via thioredoxin-1-sensitive oxidative modification of thiols on Ras[J].Circulation,2005,111(9):1192-8.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部